Aier Eye Hospital Group (300015.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Facilities · China · ISIN CNE100000GR6

Price
7.71 CNY
Market cap
71.70 bn CNY
P/E (2025)
22.19
P/S (2025)
3.21
Dividend yield
2.33 %
Net margin
14.50 %
Return on equity (ROE)
13.85 %
Return on assets (ROA)
8.83 %

Aier Eye Hospital Group financials

Fiscal year20242025
Revenue20.98 bn CNY22.35 bn CNY
Gross profit10.10 bn CNY10.53 bn CNY
Operating income4.82 bn CNY4.90 bn CNY
EBIT4.46 bn CNY4.69 bn CNY
Net income3.56 bn CNY3.24 bn CNY
Diluted EPS – continuing operations0.38 CNY0.35 CNY

Full history since 2006, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and presbyopia surgery. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 15.10.2026. Details in the risk notice.

Aier Eye Hospital Group stock (300015.SZ): P/E, revenue, dividend | finmetric